Arbutus Biopharma Corp (ABUS): EPS (Diluted)
-$0.17
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.17 | n/m | 2026-03-23, From 2025-01-01 |
| 2024-12-31 | -$0.38 | n/m | 2026-03-23, From 2024-01-01 |
| 2023-12-31 | -$0.44 | n/m | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | -$0.46 | n/m | 2024-03-05, From 2022-01-01 |
| 2021-12-31 | -$0.83 | n/m | 2023-03-02, From 2021-01-01 |
| 2020-12-31 | -$1.00 | n/a | 2022-03-03, From 2020-01-01 |
| No annual figure between 2018-12-31 and 2020-12-31. | |||
| 2018-12-31 | -$1.21 | n/m | 2019-03-07, From 2018-01-01 |
| 2017-12-31 | -$1.56 | n/m | 2019-03-07, From 2017-01-01 |
| 2016-12-31 | -$7.24 | n/m | 2018-03-16, From 2016-01-01 |
| 2015-12-31 | -$1.38 | n/c | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | -$1.80 | n/m | 2017-03-22, From 2014-01-01 |
| 2013-12-31 | -$0.92 | n/m | 2016-03-09, From 2013-01-01 |
| 2012-12-31 | $2.07 | n/m | 2015-03-13, From 2012-01-01 |
| 2011-12-31 | -$0.89 | n/a | 2014-03-28, From 2011-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | 2025-12-31 | -$0.17 | n/m |
| Opus Genetics, Inc. (IRD) | 2025-12-31 | -$0.80 | n/m |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | -$1.28 | n/m |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | -$0.01 | n/m |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | -$14.57 | n/m |
| Evommune, Inc. (EVMN) | 2025-12-31 | -$11.22 | n/m |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | -$0.12 | n/m |
| uniQure N.V. (QURE) | 2025-12-31 | -$3.46 | n/m |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | -$1.29 | n/m |
Compare ABUS, IRD, PYXS, CVSI side by side · Screen every company in Pharmaceutical Preparations ↗